Q32 Bio Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Q32 Bio Inc. (FIXX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.24% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2026-08-05
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2026-03-31 was 3.83%.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2024-09-30 was 3.53%.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2023-06-30 was 3.93%, a 16.27% increase year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2023-03-31 was 4.22%, a 123.28% increase year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2025 was 4.46%, a 2.76% increase from fiscal 2024.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.34%, a 7.07% decline from fiscal 2023.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 4.67%, a 12.26% increase from fiscal 2022.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 4.16%, a 212.78% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.24% 10-Q · filed 2026-08-05 | |||||||
| 2026-03-31 | 3.83% 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 4.46% 10-K · filed 2026-03-10 | |||||||
| 2025-09-30 | 4.46% 10-Q · filed 2025-11-13 | |||||||
| 2024-12-31 | 4.34% 10-K · filed 2026-03-10 | |||||||
| 2024-09-30 | 3.53% 10-Q · filed 2025-11-13 | 4.34% 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | 4.24% 10-Q · filed 2025-08-06 | |||||||
| 2023-12-31 | 4.67% 10-K · filed 2025-03-11 | 4.22% 10-K · filed 2024-03-13 | ||||||
| 2023-09-30 | 4.14% 10-Q · filed 2024-11-07 | 4.22% 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 3.93% 10-Q · filed 2024-08-08 | 4.03% 10-Q · filed 2023-08-14 | 3.93% 10-Q · filed 2024-08-08 | 4.22% 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 4.22% 10-Q · filed 2023-05-11 | |||||||
| 2022-12-31 | 4.16% 10-K · filed 2024-03-13 | |||||||
| 2022-09-30 | 3.66% 10-Q · filed 2023-11-14 | 3.66% 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | 3.38% 10-Q · filed 2023-08-14 | 3.38% 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 1.89% 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 1.33% 10-K · filed 2023-03-09 | |||||||
| 2021-09-30 | 1.03% 10-Q · filed 2022-11-10 | 1.20% 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | 1.20% 10-Q · filed 2022-08-15 | 1.20% 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 0.76% 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | 1.73% 10-K · filed 2022-03-23 | |||||||
| 2020-09-30 | 0.40% 10-Q · filed 2021-11-15 | 1.73% 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | 0.54% 10-Q · filed 2021-08-12 | 1.73% 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | 1.73% 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | 2.60% 10-K · filed 2021-03-11 | |||||||
| 2019-09-30 | 1.94% 10-Q · filed 2020-11-09 | 2.60% 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | 2.38% 10-Q · filed 2020-08-10 | 2.60% 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | 2.60% 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | 3.08% 10-K · filed 2020-03-12 | |||||||
| 2018-09-30 | 3.00% 10-Q · filed 2019-11-12 | 3.00% 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 2.84% 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | 2.69% 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | 2.37% 10-K · filed 2019-03-12 | |||||||
| 2017-09-30 | 2.28% 10-Q · filed 2018-11-13 | |||||||
| 2017-06-30 | 2.28% 10-Q · filed 2018-08-13 | |||||||
| 2017-03-31 | 2.31% 10-Q · filed 2018-05-14 |